{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2293, 
        2299
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2300, 
        2309
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2375, 
        2391
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        525, 
        533
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2205, 
        2220
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2222, 
        2227
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        664, 
        679
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2284, 
        2292
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2228, 
        2234
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2242, 
        2257
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160503235617|8E5E3F25058D009336038E9DC2218C0B6D3D0671|ORU^R01|999999999999|P|2.5||||||\nPID|1||N999999999^^^^CMR^HOSPITAL 9&9999&MOH~N999999999^^^^MRN^HOSPITAL 9&9999&MOH~9999999999&BC&ON^^^^JHN||XXXXX^XXXXXX^ XXXXX^^^^||99999999|F|||99 XXXXXXXXXX XXX^^XXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|||\nOBR|1||S16-10958|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160428|||56746^XXXXXXX^XXXX^^^^||||||||||||20160503|||F|||||||99999^XXXXXX^XXXX^^^^|||||||\n\n\n\n\n\n\n\nCOMMENTS\n\nSpecimen: A\nExcision time: 1500\nTime placed in Formalin: 1501\n\n\nTISSUE SUBMITTED\n\nBREAST BIOPSY (RT BREAST 0.5 CM SHADOWING L)\n\n\nGROSS PATHOLOGY\n\nThe specimen is received in formalin, labelled with the patient's name and as \"right breast 0.5 cm shadowing lesion 9-10\". The specimen\nconsists of three fibrofatty core biopsies measuring 0.9 cm to 1.2 cm in length by\n0.2 cm in diameter, and a fragment of fatty tissue measuring 0.2 cm in maximum\ndimension. Entirely submitted as follows:\nA1    -  two cores\nA2    -  one core and one fragment\n                                        /SM\n\n\nMICROSCOPIC DESCRIPTION\n\nESTROGEN AND PROGESTERONE RECEPTOR PROTEIN IMMUNOHISTOCHEMISTRY\nDIAGNOSIS:\nINVASIVE DUCTAL CARCINOMA:\n- POSITIVE FOR ESTROGEN RECEPTORS\n- POSITIVE FOR PROGESTERONE RECEPTORS\nRESULT:\n(Block A1)\n99% of cell nuclei are positive for estrogen receptors (STRONG)\n99% of cell nuclei are positive for progesterone receptors (STRONG)\nAntibody used:\nEstrogen receptor (Rabbit monoclonal, Clone SP1, Ventana)\nProgesterone receptor (Rabbit Monoclonal, Clone 1E2, Ventana)\nPositive and negative external laboratory controls, and internal\ncontrol normal breast tissue stained appropriately.\n\nThreshold for interpretation of Estrogen and Progesterone\nreceptors as per CCO guidelines:\nPOSITIVE: 10% or more of tumor cell nuclei stain positively with any intensity\nLOW POSITIVE: 1-9% of tumor cell nuclei stain positively with any intensity\nNEGATIVE: <1% of tumor cell nuclei stain positively with any intensity\nReference:\nDiaz LK, Sneige N: Estrogen receptor analysis for breast cancer: current\nissues and keys to increasing testing accuracy. Adv Anat Pathol\n2005;12:10-19\n\n\nFINAL DIAGNOSIS\n\nRIGHT BREAST LESION AT 9-10 O'CLOCK, NEEDLE CORE BIOPSY:\n   - INVASIVE DUCTAL CARCINOMA\n   - POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS\n(CODE 1)\n\n\nCLINICAL HISTORY\n\nRIGHT BREAST SHADOWING SOLID LESION\n\n\n"
}